Paper Details

  1. Home
  2. Paper Details

Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features.

Author: BellmuntJ, BerkenblitA, FeingoldJ, StrahsA, SzczylikC

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study reviewed adverse events associated with temsirolimus, a mammalian target of rapamycin inhibitor, in patients with advanced renal cell carcinoma. Temsirolimus was effective in extending survival, but it was associated with a range of side effects.
Paper Details　
Original Abstract of the Article :
Temsirolimus, a novel inhibitor of mammalian target of rapamycin, has demonstrated prolonged overall survival and progression-free survival compared with interferon alfa (IFN) in patients with advanced renal cell carcinoma (RCC) and poor prognostic features. Adverse events (AEs) of any causality wer...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/annonc/mdn066

データ提供：米国国立医学図書館（NLM）

Temsirolimus: A Novel Treatment for Advanced Renal Cell Carcinoma

This study explores the safety profile and management of toxic effects associated with temsirolimus, a novel inhibitor of mammalian target of rapamycin (mTOR) used to treat advanced renal cell carcinoma (RCC). It's like navigating the desert of cancer treatment, searching for the safest and most effective path for patients facing this challenging disease. The study focuses on the potential side effects of temsirolimus, providing valuable insights for clinicians managing patients with RCC.

Temsirolimus: A Promising Treatment Option

The study highlights the potential of temsirolimus to improve overall survival and progression-free survival in patients with advanced RCC, especially those with poor prognostic features. This is significant news for patients with this challenging disease, offering a potential lifeline and a new avenue for treatment. It's like finding a hidden oasis in the desert of cancer treatment, providing a source of hope and a path towards recovery.

Navigating the Side Effects

The study emphasizes the importance of understanding and managing the potential side effects of temsirolimus, particularly for patients with poor prognostic features. It's like navigating a desert with treacherous terrain, requiring careful planning and vigilance to avoid potential hazards. The study's findings provide valuable information for clinicians to effectively manage potential side effects and ensure the best possible outcomes for patients receiving temsirolimus treatment.

Dr.Camel's Conclusion

This study is a valuable contribution to the field of renal cell carcinoma treatment, offering insights into the safety profile and management of temsirolimus. It's like discovering a new guidebook for navigating the desert of cancer treatment, providing valuable information for clinicians and patients alike. The study's findings underscore the importance of careful monitoring and management of potential side effects, ensuring that patients receive the most effective and safe treatment possible.

Date :
  1. Date Completed 2008-08-21
  2. Date Revised 2022-03-10
Further Info :

Pubmed ID

18385198

DOI: Digital Object Identifier

10.1093/annonc/mdn066

Related Literature

Article Analysis
・Effects of temsirolimus
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.